A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Clinical trial NCT06925542 · RECRUITING

Trial details

NCT number: NCT06925542
Sponsor: CRISPR Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

SLE (Systemic Lupus)Lupus Erythematosus, Systemic Lupus Nephritis Systemic Sclerosis Inflammatory Myopathy, Idiopathic Myositis Diffuse Cutaneous Systemic Sclerosis

Start date: 2025-03-10
Primary completion: 2031-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.